Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

autologous tumor-infiltrating lymphocytes MDA-TIL

A preparation of autologous tumor-infiltrating lymphocytes (TILs) with potential antineoplastic activity. TILs are isolated from a patient’s tumor tissue, then cultured and expanded in vitro in the presence of interleukin-2 (IL-2) and an agonistic anti-4-1BB (CD137) antibody. Upon infusion of the autologous expanded TILs back into the patient, the cells specifically recognize, target, and kill the patient’s tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:MDA autologous TILs
MDA autologous tumor-infiltrating lymphocytes
Code name:MDA-TILs
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search